AbbVie Stock Surges 1.98% in Two Days, Trading Volume Ranks 40th

AbbVie (ABBV) shares rose 1.27% on March 28, 2025, marking the second consecutive day of gains, with a total increase of 1.98% over the past two days. The trading volume reached 13.24 billion, placing it 40th in the day's market activity.

AbbVie has recently completed the acquisition of Nimble Therapeutics, integrating the company into its operations. This strategic move is expected to enhance AbbVie's portfolio and market position.

Investors are closely watching AbbVie's performance, with the company anticipated to report earnings of $2.51 per share for the current quarter, reflecting an 8.7% increase from the same period last year. This positive outlook has garnered attention from various investment strategies, including those focused on low volatility and strong momentum.

Orion Portfolio Solutions LLC has increased its holdings in AbbVie by 3.6% in the fourth quarter, indicating confidence in the company's future prospects. This institutional investment further supports the positive sentiment surrounding AbbVie's stock.